{
  "id": 4844059,
  "title": "Satellos to Participate in Upcoming Investor Conferences",
  "url": "https://urgent.news/2026/09/01/satellos-to-participate-in-upcoming-investor-conferences",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-01T11:02:25.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/satellos-to-participate-in-upcoming-investor-conferences-3"
  },
  "original_language": "en",
  "account": null,
  "summary": "TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) — Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative muscle diseases, today announced that management will participate in the following investor conferences in September. 2026 Cantor Global Healthcare ConferenceDate: Wednesday, September 9,…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Financial Post",
        "title": "enGene to Participate in Upcoming Investor Conferences",
        "url": "https://urgent.news/2026/09/01/engene-to-participate-in-upcoming-investor-conferences",
        "published": "2026-09-01T12:34:38.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}